Metabolon | Sample Collection

Sample Collection

We’ve collaborated with companies to deliver the devices designed for ambient-temperature storage and transport of human samples for metabolomic analysis.

Talk to an Expert

The Need for Small Volume and At-Home Collection Devices

Traditional sample collection and storage methods come with a variety of challenges. Human sample collection may require a clinic visit and invasive collection by trained staff. Flash or rapid-freezing is the gold standard, so the collection site may need to have cold storage on hand. The availability of storage can introduce variability to the sample testing.

Advantages of Small Volume and At-Home Collection Devices

The ability to collect sample as home makes sample collection convenient for patients. Sample collection that does not require cold storage reduces sample variability and cost effectiveness.

R Easy, private, comfortable collection

Improve patient experience and compliance with self-collection of high-quality samples, with no clinic visit or at-home sample freezing required.

R Validated for Metabolon’s Global Discovery Panel

Our validation studies have shown these devices protect and preserve the metabolomic profile of collected samples at room temperature for Metabolon’s Global Discovery Panel.

R Supports a multi-omics approach

Metabolon-validated devices have the same user experience as other commonly used sample collection devices. This provides a familiar and tested method of at-home collection to reliably implement a multi-omics approach in your research.

R Metabolon study success

Sample collection tubes are barcoded for sample traceability and compatibility with Metabolon’s Study Success Sample Handling Kit. These are supported as a Metabolon Preferred option for human samples to achieve the fastest and most reliable results.

Validation of Small Volume and At-Home Collection Devices for Untargeted Metabolomics

Existing at-home collection methods are either not-suitable or not-tested for untargeted metabolomics. Typical devices often use salts and detergents that are incompatible with liquid chromatography mass spectrometry (LC/MS). Some may contain reagents that create unwanted reactivity. Any devices must maintain the metabolomic profile of the sample without a loss of sensitivity and accuracy. Metabolon validates at-home collection devices for sensitivity, precision, fidelity, stability and field testing. Validation ensures that the data generated from samples collected using these devices are reliable and accurate. Validation is essential for making informed decisions in research, clinical diagnostics, and patient care. Validation facilitates integration with our Global Discovery Panel workflow.

Neoteryx—The Blood Microsampling Innovator

The Neoteryx VAMS device makes blood sampling convenient and efficient to collect and transport blood samples for testing, ensuring faster and more accessible analyses and diagnostics.

Learn more about Neoteryx sampling

Whatman—Dried Blood Spot Cards

Whatman 903 cards are well established in clinical testing (newborn screening) and are easy-to-use and amenable to both at-home collection and easy laboratory handling.

Learn more about Whatman sampling

DNAgenotek—OMNImet™•GUT Fecal Sample Collection

OMNImet•GUT (ME-200) is an all-in-one system for easy at-home collection, homogenization and room temperature stabilization of targeted and untargeted metabolites from fecal samples.

Learn more about OMNImet·GUT sampling

Talk with an expert

Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.



Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709



+1 (919) 572-1711



+1 (919) 572-1721

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.